Filing Details

Accession Number:
0000899243-21-003114
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-22 21:36:27
Reporting Period:
2021-01-21
Accepted Time:
2021-01-22 21:36:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501134 Invitae Corp NVTA Services-Medical Laboratories (8071) 271701898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1627766 E Sean George C/o Invitae Corporation
1400 16Th Street
San Francisco CA 94103
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-21 5,000 $8.70 646,018 No 4 M Direct
Common Stock Disposition 2021-01-21 7,003 $53.60 639,015 No 4 S Direct
Common Stock Disposition 2021-01-21 1,272 $54.27 637,743 No 4 S Direct
Common Stock Disposition 2021-01-21 400 $55.69 637,343 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Options (right to buy) Disposition 2021-01-21 5,000 $0.00 5,000 $8.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,000 2024-10-15 No 4 M Direct
Footnotes
  1. Includes an aggregate of 282,848 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
  2. These sales of common stock were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2020.
  3. Represents a weighted average sale price. Actual sale prices ranged from $53.02 to $53.99 per share.
  4. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
  5. Represents a weighted average sale price. Actual sale prices ranged from $54.03 to $54.77 per share.
  6. Represents a weighted average sale price. Actual sale prices ranged from $55.46 to $55.89 per share.
  7. The shares subject to this option are fully vested and exercisable.